Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey

Leech, B; Schloss, J; Steel, A

Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey

Leech, B Schloss, J

Steel, A

Permalink

Publication Type:: Journal Article
Citation:: Complementary Therapies in Clinical Practice, 2018, 31 pp. 200 - 209
Issue Date:: 2018-05-01

Closed Access

	Filename	Description	Size
	1-s2.0-S1744388117305388-main.pdf	Published Version	389.5 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Leech, B	en_US
dc.contributor.author	Schloss, J https://orcid.org/0000-0003-1643-6215	en_US
dc.contributor.author	Steel, A https://orcid.org/0000-0001-6643-9444	en_US
dc.date.available	2018-02-21	en_US
dc.date.issued	2018-05-01	en_US
dc.identifier.citation	Complementary Therapies in Clinical Practice, 2018, 31 pp. 200 - 209	en_US
dc.identifier.issn	1744-3881	en_US
dc.identifier.uri	http://hdl.handle.net/10453/129234
dc.description.abstract	© 2018 Elsevier Ltd Background: This study aims to explore the conditions complementary and integrative medicine (CIM) practitioners associate with increased intestinal permeability (IP) and the methods they employ to assess IP. Methods: A cross-sectional survey of naturopaths, nutritionists and Western herbal medicine practitioners was undertaken (n = 227) through the Practitioner Research and Collaboration Initiative (PRACI) network. Results: CIM practitioners (n = 36, response rate 15.9%) associate IP with gastrointestinal (100.0%), autoimmune (91.7%), skin (91.7%), neurological (80.6%), respiratory (55.6%) and liver-related conditions (44.4%). CIM practitioners frequently treat IP (72.7%); observing a minimum 3 months of treatment is required to resolve IP. Patient's signs and symptoms were the main reasons CIM practitioners suspected IP (94.1%). Conclusion: CIM practitioners observe a clinical link between IP and a wide range of conditions, including those not yet recognised within the literature. The clinical experience of CIM practitioners holds substantial value to the advancement of research and the clinical management of IP.	en_US
dc.relation.ispartof	Complementary Therapies in Clinical Practice	en_US
dc.relation.isbasedon	10.1016/j.ctcp.2018.02.014	en_US
dc.subject.classification	Complementary & Alternative Medicine	en_US
dc.subject.mesh	Gastrointestinal Tract	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Gastrointestinal Diseases	en_US
dc.subject.mesh	Intestinal Diseases	en_US
dc.subject.mesh	Liver Diseases	en_US
dc.subject.mesh	Respiratory Tract Diseases	en_US
dc.subject.mesh	Nervous System Diseases	en_US
dc.subject.mesh	Autoimmune Diseases	en_US
dc.subject.mesh	Complementary Therapies	en_US
dc.subject.mesh	Naturopathy	en_US
dc.subject.mesh	Phytotherapy	en_US
dc.subject.mesh	Nutrition Therapy	en_US
dc.subject.mesh	Cross-Sectional Studies	en_US
dc.subject.mesh	Dietetics	en_US
dc.subject.mesh	Permeability	en_US
dc.subject.mesh	Health Personnel	en_US
dc.subject.mesh	Physicians	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.subject.mesh	Integrative Medicine	en_US
dc.subject.mesh	Surveys and Questionnaires	en_US
dc.title	Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey	en_US
dc.type	Journal Article
utslib.citation.volume	31	en_US
utslib.for	1104 Complementary and Alternative Medicine	en_US
utslib.for	1110 Nursing	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access
pubs.publication-status	Published	en_US
pubs.volume	31	en_US

Abstract:

© 2018 Elsevier Ltd Background: This study aims to explore the conditions complementary and integrative medicine (CIM) practitioners associate with increased intestinal permeability (IP) and the methods they employ to assess IP. Methods: A cross-sectional survey of naturopaths, nutritionists and Western herbal medicine practitioners was undertaken (n = 227) through the Practitioner Research and Collaboration Initiative (PRACI) network. Results: CIM practitioners (n = 36, response rate 15.9%) associate IP with gastrointestinal (100.0%), autoimmune (91.7%), skin (91.7%), neurological (80.6%), respiratory (55.6%) and liver-related conditions (44.4%). CIM practitioners frequently treat IP (72.7%); observing a minimum 3 months of treatment is required to resolve IP. Patient's signs and symptoms were the main reasons CIM practitioners suspected IP (94.1%). Conclusion: CIM practitioners observe a clinical link between IP and a wide range of conditions, including those not yet recognised within the literature. The clinical experience of CIM practitioners holds substantial value to the advancement of research and the clinical management of IP.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/129234